2022-2029 年 Western Blot 處理器的全球市場
市場調查報告書
商品編碼
1140713

2022-2029 年 Western Blot 處理器的全球市場

Global Western Blotting Processors Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

在蛋白質組學研究中越來越多地採用蛋白質印跡處理器推動市場增長

蛋白質印跡處理器市場主要由蛋白質組學和基因組學研究驅動。Western印跡是分子生物學和蛋白質組學中最常用的技術之一。Western blotting是分子生物學和蛋白質組學中最常用的技術之一,但由於該技術是一個連續的框架,每一步都會發生變化和不准確,限制了該技術的可重複性和不准確性,並可能降低可靠性。蛋白質組學可以分析和識別翻譯後修飾、蛋白質-蛋白質相互作用和蛋白質周轉。隨著對高效和個性化醫學的開發越來越關注,全球對蛋白質印跡處理器的需求正在增加。

對個性化醫療的日益關注也有助於預測期內的市場增長。越來越多地採用個性化治療癌症正在推動採用蛋白質印跡處理器。個性化醫療有可能提供最高的反應和最高的安全邊際,以確保更好的患者護理。個性化醫療有可能在降低成本的同時改善醫療保健的多個方面,這有望成為市場增長的積極指標。根據個性化醫學聯盟的數據,生物製藥研究人員預測,未來五年正在開發的個性化藥物數量將增加 69%。

地理滲透。

北美是預測期內的主要地區。

該研究按地區分析了全球市場的蛋白質印跡處理器市場,包括北美、南美、歐洲、亞太地區、中東和非洲。

蛋白質印跡處理器在北美的價值和數量佔全球最大份額,其次是歐洲和亞太地區。2022年北美Western Blot Processor市場由美國主導。這是由於萊姆病和艾滋病毒的流行率增加、研究資金增加、轉基因作物產量增加以及研究會議增加。美國的幾個主要參與者正在通過推出新的學習中心來幫助他們發展市場。例如,2021 年 1 月,Bio-Rad Laboratories 推出了蛋白質印跡學習中心和在線學習平台,為研究人員改進實驗蛋白質印跡提供信息和指導。該學習中心位於 bio-rad.com。該中心提供有關蛋白質印跡科學、最佳實踐、提示和技巧、實驗故障排除指南等的全面信息。

此外,預計亞太地區將在預測期內顯示出西方印跡處理器市場最快的增長率。中國在市場上占主導地位,據估計,在預測期內,印度在亞太地區的蛋白質印跡處理器市場將出現大幅增長。

競爭格局。

由於 Western Blot Processor 品牌眾多,Western Blot Processor 市場是一個競爭激烈的市場。主要的蛋白質印跡處理器製造商有 Bio-Rad Laboratories, Inc.、Cell Signaling Technology、Advansta Inc.、Li-Cor Biosciences、Bio-Techne Corporation、GE Healthcare、Cytoskeleton Inc.、PerkinElmer Inc.、F. Hoffmann-La Roche Ltd.。 , Merck KGaA., Bio-Key, Bio-Rad, Cell Signaling Technology Inc.主要參與者正在採用新產品發布和擴張戰略來促進蛋白質印跡處理器的全球增長。一些主要的主要參與者正在遵循併購策略來擴展他們的業務。例如,2021 年 4 月,Bio-techne 完成了對 Asuragen, Inc. 的收購。此次收購有助於擴大公司一流的分子診斷和研究產品的產品組合,包括基因篩查、腫瘤檢測試劑盒和分子控制。同樣在 2022 年 7 月,Bio-Techne 宣布已完成對 Namocell, Inc. 的收購。此次收購增加了一個易於使用的單細胞分選和移液平台,該平台對細胞友好並保持細胞活力和完整性。2022年1月,Bio-techne宣布商業發布用於jess自動化免疫印跡系統的高靈敏度熒光檢測Stellar NIR/IR模塊。這個新模塊能夠檢測低豐度蛋白質,同時在同一檢測通道內多路復用多種分析物。該模塊為蛋白質印跡中的熒光檢測靈敏度設立了新的行業標準。

COVID-19 的影響。它將對 Western Blot Processor 全球市場產生積極影響。

在 COVID-19 中蛋白質印跡處理器使用範圍擴大的背景下,蛋白質印跡處理器市場的規模預計將在 2020 年擴大。應考慮使用蛋白質印跡來確認篩查測試(如 ELISA)中的陽性或臨界陽性結果。蛋白質印蹟的另一個好處是識別可能成為疫苗開發基礎的抗原。蛋白質印跡法用於確定 COVID-19 康復患者血清識別的蛋白質抗原,以及哪些病毒應作為單價疫苗或疫苗混合物的一部分,尤其是在不使用減毒活病毒時。由此可見,大流行期間對蛋白質印蹟的需求增加了,蛋白質印跡處理器市場的需求也增加了。因此,在 COVID-19 大流行期間,對蛋白質印跡處理器的需求增加,導致 2020 年的銷售額增加。

Western Blot Processor 全球市場報告提供了大約 61 個市場數據表、54 個數字和 170 頁的結構。

目錄

第一章 調查方法和範圍

  • 調查方法
  • 調查目的和範圍

第二章市場定義和概述

第三章執行摘要

  • 按產品劃分的市場細分
  • 按應用劃分的市場細分
  • 最終用戶的市場細分
  • 區域市場細分

第四章市場動態

  • 市場影響因素
    • 促進者
      • 艾滋病毒/艾滋病流行率增加
      • 製藥公司研發費用增加
    • 抑製劑
      • 替代品的出現
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 中的價格動態
  • 供需譜
  • 大流行期間與市場相關的政府努力
  • 製造商的戰略舉措
  • 概括

第 7 章按產品分類

  • 消耗品
  • 樂器

第 8 章 按申請

  • 生物醫學和生化研究
  • 疾病診斷
  • 農業領域
  • 其他

第 9 章最終用戶

  • 學術/研究機構
  • 製藥和生物技術公司
  • 診斷中心
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東/非洲

第 11 章 競爭格局

  • 競爭情景
  • 市場/份額分析
  • 併購分析

第 12 章 Western Blot 處理器市場-公司簡介

  • Bio-Rad Laboratories, Inc.
    • 公司簡介
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • Bio-Techne Corporation
  • Advansta Inc.
  • Cell Signaling Technology
  • Li-Cor Biosciences
  • Cytoskeleton Inc.
  • GE Healthcare
  • PerkinElmer Inc.
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd.(List Not Exhaustive)

第 13 章 重要注意事項

第 14 章 數據管理

簡介目錄
Product Code: DMHCIT3087

Market Overview

Western Blotting Processors Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029)

Western blotting is an analytical technique used to separate and detect specific proteins based on the relative molecular mass of proteins. Western blotting processors are devices used to do western blotting techniques to attain high sensitivity and specificity, facilitating detection of preferred protein with a concentration nearly ten times lesser than the threshold of detection. The results attained with the conventional western blotting processors are relatively unreliable, tedious and require technical expertise, which is addressed by the automated western blot processors. Certain factors leading the market growth include the increasing prevalence of HIV/AIDS, the increasing R&D expenditure by pharmaceutical and biotechnology companies, and untapped opportunities in emerging markets.

Market Dynamics: Rising adoption of western blotting processor in increasing proteomics research drives market growth

The market for western blotting processors is considerably driven by proteomics and genomics research. Western blotting is one of the most commonly used techniques in molecular biology and proteomics. Because it is a sequential framework, differences and inaccuracies could even take place at any stage, decreasing this particular method's reproducibility and reliability. Proteomics approaches include the characterization and identification of post-translational modifications, protein-protein interaction, protein turnovers, and more. With the rising focus on the development of efficient, personalized medicine, the demand for western blotting processors is increasing globally.

Also, increasing focus on personalized medicine helps to grow the market in the forecast period. The increasing adoption of personalized medicines for cancer is augmenting the adoption of western blotting processors. Personalized medicine has the potential to provide the best response and highest safety margin to ensure better patient care. Personalized medicine has the potential to improve several aspects of healthcare while lowering costs, which is expected to be a positive indicator of the growth of the market. According to Personalized Medicine Coalition, biopharmaceutical researchers predict a 69% increase in the number of personalized medicines in development over the next five years.

Market Segmentation: Disease diagnostics segment will project the fastest growth in the market throughout the forecast period

Based on the application, the western blotting processors market has been classified into biomedical & biochemical research, disease diagnostics, agriculture, and others.

The disease diagnostics segment dominated the western blotting processor market in 2022. This is due to a rise in the increasing incidences of target diseases, such as Hepatitis and Lyme disease, across the globe. A diagnostics test is a kind of medical test performed to aid in the diagnosis or detection of a disease. Disease diagnostic tests are used to provide prognostic information on people with established diseases. Healthcare professionals use symptoms and signs as clues that can help to determine the most likely diagnosis when illness is present. Moreover, the use of these devices to identify specific protein molecules from a mixture of protein samples in proteomics and genetic science are certain key factors expected to drive market growth in the forecast period.

Based on the end-user, the western blotting processors market has been classified into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others.

Academic & research institutes lead the market throughout the forecast period. Several research activities ongoing in the academic & research laboratories are augmenting the demand for western blotting processors. The major demand is driven across the developed and emerging nations, such as the United States, United Kingdom and Germany.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the western blotting processors market in the global market, including North America, South America, Europe, Asia-Pacific, and the Middle East & Africa.

North America dominated the global western blotting processors market with the largest share in value and volume globally, followed by Europe and the Asia Pacific. The United States dominated the North American western blotting processors market in 2022. It is owing to the increasing prevalence of Lyme disease and HIV, the rise in research funding and growing production of genetically modified crops, and the rising number of research conferences. Some major key players in the United States help grow the the market by launching new learning centers. For instance, in January 2021, Bio-Rad laboratory launched its Western Blot Learning Centre and online learning platform, which provide information and guidance to help researchers to improve their experimental western blotting. This learning Centre is available on bio-rad.com. This Centre offered comprehensive information on the science of western blotting, best practices, tips and techniques, and guidance on troubleshooting experiments.

Moreover, Asia Pacific is expected to project the fastest growth rate in the western blotting processors market during the forecast period. China dominates the market, whereas India is estimated to exhibit considerable growth in the Asia Pacific western blotting processors market during the forecast period.

Competitive Landscape:

The western blotting processors market is highly competitive, owing to the large presence of western blotting processors brands. The key western blotting processors players include Bio-Rad Laboratories, Inc., Cell Signaling Technology, Advansta Inc., Li-Cor Biosciences, Bio-Techne Corporation, GE Healthcare, Cytoskeleton Inc., PerkinElmer Inc., F. Hoffmann-La Roche Ltd., Merck KGaA. The crucial players are adopting new product launches and expansion strategies for global growth in the western blotting processors. Some major key players follow merger and acquisition strategies to expand their business. For instance, in April 2021, Bio-techne completed the acquisition of Asuragen, Inc. This acquisition helped to increase the product portfolio of best-in-class molecular diagnostic and research products like genetic screening, oncology testing kits, and molecular controls. Also, in July 2022, Bio-Techne announced it had completed the acquisition of Namocell, Inc. This acquisition adds easy-to-use single-cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. In January 2022, Bio-techne announced the commercial release of high sensitivity fluorescent detection stellar NIR / IR modules for jess's automated western blotting system. This new module allowed the detection of low abundance proteins while multiplexing multiple analytes within the same detection lane. This module sets a new industry standard for western blotting fluorescence detection sensitivity.

COVID-19 Impact: Positive impact on the global western blotting processors market.

An increase in the market value of western blotting processors is expected in 2020, backed by the increasing application of western blotting processors in COVID-19. Western blots should be considered for confirming a positive or borderline-positive result from a screening test, such as an ELISA. An additional benefit of Western blots would be to identify antigens that could form the basis for developing a vaccine. Western blot technic used to determine which protein antigens are recognized by sera from patients recovering from COVID-19 in order to better identify those components of the virus that should be part of a monovalent vaccine or a vaccine cocktail, especially if a live, attenuated virus is not used. These factors indicated that the need for western blotting increased during the pandemic owing to increasing demand for the western blotting processors market. Therefore, the demand for western blotting processors increased amid the COVID-19 pandemic, which in turn, increased its sales in 2020.

The global western blotting processors market report would provide an access to approximately 61 market data tables, 54 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of HIV/AIDS
      • 4.1.1.2. Rise in R&D spending by pharmaceutical companies
    • 4.1.2. Restraints:
      • 4.1.2.1. Emergence of alternatives
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Consumables*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Instruments

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Biomedical & Biochemical Research*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Disease Diagnostic
    • 8.3.3. Agriculture
    • 8.3.4. Others

9. By End User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 9.3. Market Attractiveness Index, By End User Segment
    • 9.3.1. Academic & Research Institutes*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Pharmaceutical & Biotechnology Companies
    • 9.3.3. Diagnostic Centers
    • 9.3.4. Others

10. By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Western Blotting Processors Market- Company Profiles

  • 12.1. Bio-Rad Laboratories, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Bio-Techne Corporation
  • 12.3. Advansta Inc.
  • 12.4. Cell Signaling Technology
  • 12.5. Li-Cor Biosciences
  • 12.6. Cytoskeleton Inc.
  • 12.7. GE Healthcare
  • 12.8. PerkinElmer Inc.
  • 12.9. Merck KGaA
  • 12.10. F. Hoffmann-La Roche Ltd. (List Not Exhaustive)

13. Premium Insights

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us